The commissioner shall adopt rules, pursuant to RSA 541-A, relative to: I. Identifying communicable diseases to be reported under RSA 141-C:8. II. The design and content of all forms required under this chapter including forms for reporting communicable diseases under RSA 141-C:8. III. Reporting required under RSA 141-C:7. IV. The conduct of investigations carried out under RSA 141-C:9, I. V. The procedure for disclosure of information under RSA 141-C:10. VI. Establishing, maintaining, and lifting the isolation and quarantine of cases, carriers, or suspected cases or carriers of communicable diseases under RSA 141-C:11. VII. Decontamination of commodities, conveyances, baggage, and cargo under RSA 141-C:11, IV. VIII. Issuing and carrying out orders for the treatment and care and for the restriction and control of diseases under RSA 141-C:15. IX. Distribution of pharmaceutical agents under RSA 141-C:17. X. Laboratory testing, fee schedules, and the waiving of fees under RSA 141-C:19. XI. Regulating use of the common cup under RSA 141-C:4, VIII. XII. The procedure for written orders under RSA 141-C:12. XIII. Other communicable diseases requiring immunization under RSA 141-C:20-a, I. XIV. The child's age for administration of a vaccine for immunization. XV. The number of doses necessary for each vaccine. XVI. The acceptable level of immunization necessary for a child to be enrolled in a school or child care agency under RSA 141-C:20-a, II(b). XVII. Procedures for keeping immunization records under RSA 141-C:20-b, II. XVIII. The immunization registry established under RSA 141-C:20-f. XIX. Identifying microbial isolates of reportable diseases and patient specimens to be retained or forwarded to the public health laboratories. XX. Establishing a registry of biological agents present in New Hampshire. XXI. Procedures relating to information, specimens, and samples as required under RSA 141-C:10, IV. XXII. Procedures for administration of and disbursement from the mosquito control fund, established in RSA 141-C:25.
The commissioner shall adopt rules, pursuant to RSA 541-A, relative to: I. Identifying communicable diseases to be reported under RSA 141-C:8. II. The design and content of all forms required under this chapter including forms for reporting communicable diseases under RSA 141-C:8. III. Reporting required under RSA 141-C:7. IV. The conduct of investigations carried out under RSA 141-C:9, I. V. The procedure for disclosure of information under RSA 141-C:10. VI. Establishing, maintaining, and lifting the isolation and quarantine of cases, carriers, or suspected cases or carriers of communicable diseases under RSA 141-C:11. VII. Decontamination of commodities, conveyances, baggage, and cargo under RSA 141-C:11, IV. VIII. Issuing and carrying out orders for the treatment and care and for the restriction and control of diseases under RSA 141-C:15. IX. Distribution of pharmaceutical agents under RSA 141-C:17. X. Laboratory testing, fee schedules, and the waiving of fees under RSA 141-C:19. XI. Regulating use of the common cup under RSA 141-C:4, VIII. XII. The procedure for written orders under RSA 141-C:12. XIII. Other communicable diseases requiring immunization under RSA 141-C:20-a, I. XIV. The child's age for administration of a vaccine for immunization. XV. The number of doses necessary for each vaccine. XVI. The acceptable level of immunization necessary for a child to be enrolled in a school or child care agency under RSA 141-C:20-a, II(b). XVII. Procedures for keeping immunization records under RSA 141-C:20-b, II. XVIII. The immunization registry established under RSA 141-C:20-f. XIX. Identifying microbial isolates of reportable diseases and patient specimens to be retained or forwarded to the public health laboratories. XX. Establishing a registry of biological agents present in New Hampshire. XXI. Procedures relating to information, specimens, and samples as required under RSA 141-C:10, IV. XXII. Procedures for administration of and disbursement from the mosquito control fund, established in RSA 141-C:25.
The commissioner shall adopt rules, pursuant to RSA 541-A, relative to: I. Identifying communicable diseases to be reported under RSA 141-C:8. II. The design and content of all forms required under this chapter including forms for reporting communicable diseases under RSA 141-C:8. III. Reporting required under RSA 141-C:7. IV. The conduct of investigations carried out under RSA 141-C:9, I. V. The procedure for disclosure of information under RSA 141-C:10. VI. Establishing, maintaining, and lifting the isolation and quarantine of cases, carriers, or suspected cases or carriers of communicable diseases under RSA 141-C:11. VII. Decontamination of commodities, conveyances, baggage, and cargo under RSA 141-C:11, IV. VIII. Issuing and carrying out orders for the treatment and care and for the restriction and control of diseases under RSA 141-C:15. IX. Distribution of pharmaceutical agents under RSA 141-C:17. X. Laboratory testing, fee schedules, and the waiving of fees under RSA 141-C:19. XI. Regulating use of the common cup under RSA 141-C:4, VIII. XII. The procedure for written orders under RSA 141-C:12. XIII. Other communicable diseases requiring immunization under RSA 141-C:20-a, I. XIV. The child's age for administration of a vaccine for immunization. XV. The number of doses necessary for each vaccine. XVI. The acceptable level of immunization necessary for a child to be enrolled in a school or child care agency under RSA 141-C:20-a, II(b). XVII. Procedures for keeping immunization records under RSA 141-C:20-b, II. XVIII. The immunization registry established under RSA 141-C:20-f. XIX. Identifying microbial isolates of reportable diseases and patient specimens to be retained or forwarded to the public health laboratories. XX. Establishing a registry of biological agents present in New Hampshire. XXI. Procedures relating to information, specimens, and samples as required under RSA 141-C:10, IV. XXII. Procedures for administration of and disbursement from the mosquito control fund, established in RSA 141-C:25.
